Breaking
Monday, July 27, 2026

Regulatory Updates

🇺🇸 FDA

FDA news and analysis for pharmaceutical BD, investment, and market access

Track global pharma regulatory policy changes, FDA, EMA, and other agency guidelines impacting drug development and market access. Stay ahead.

Showing 1–12 of 380 articles

Quick answer

NovaPharmaNews Regulatory Updates hub for FDA covers 380 published articles — news and analysis for pharma BD, investors, and market access teams. Browse related topics below or explore companies, pipeline, and events linked from each story.

Standard impact NewsJul 26, 2026

Monopar Starts Rolling NDA for ALXN1840 Wilson

FDA · Rare Diseases · 3 min

Sarah Chen
Standard impact NewsJul 24, 2026

FDA Accepts Daraxonrasib NDA for Pancreatic Cancer

FDA · Oncology · 3 min

Sarah Chen
Standard impact NewsJul 22, 2026

Commissioner National Priority Voucher CNPV Pilot

FDA · Regulatory Policy · 3 min

Sarah Chen
Standard impact NewsJul 22, 2026

FDA Finalizes Guidance on Clinical Trial Design

FDA · Psychiatry · 3 min

Sarah Chen
Standard impact NewsJul 22, 2026

FDA Activity Round Up July 2026

FDA · 3 min

Sarah Chen
Standard impact NewsJul 22, 2026

Drug Repurposing Stakeholders Say FDA Should Act

FDA · 3 min

Sarah Chen
Standard impact NewsJul 22, 2026

Compounded GLP-1s Why doctors worry and FDA acts

FDA · Metabolic Disorders · 3 min

Sarah Chen
High impact NewsJun 16, 2026

FDA approves OTC Rextovy, broadening naloxone access for opioid overdose

FDA · opioid overdose · 6 min

Sarah Chen
High impact AnalysisJun 16, 2026

Lilly buys 4E in non-opioid pain push: what investors should watch

FDA · moderate to severe acute pain · 6 min

Sarah Chen
High impact NewsJun 16, 2026

Lilly’s early JAK data raises myelofibrosis competition question

FDA · myelofibrosis · 6 min

Sarah Chen
Critical impact NewsJun 16, 2026

FDA authorizes emergency pet treatment for New World screwworm

FDA · New World screwworm · 4 min

Michael Rodriguez
High impact NewsJun 15, 2026

FDA guidance on sharing potential NDA patent information: what changes now

FDA · 4 min

Sarah Chen

Frequently asked questions

How often is this topic updated?

New articles are published continuously as regulatory, clinical, and commercial signals break. Use the content-type filters for latest news vs in-depth analysis.

Where does this coverage come from?

Editorial intelligence combines FDA openFDA, ClinicalTrials.gov, SEC EDGAR, congress calendars, and analyst reporting. See our data sources policy for attribution.